Sumalinog, Juryl B.
HRN: 22-08-83 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2022
CEFUROXIME 750MG (VIAL)
11/21/2022
11/26/2022
IVT
750mg
Q8 X 5 Days
S/P LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: No Wrong Dose Wrong Dose
Overall appropriateness: No Wrong Dose